These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 9190900)

  • 41. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.
    Nilsson JA; Keller UB; Baudino TA; Yang C; Norton S; Old JA; Nilsson LM; Neale G; Kramer DL; Porter CW; Cleveland JL
    Cancer Cell; 2005 May; 7(5):433-44. PubMed ID: 15894264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of c-myc and ornithine decarboxylase expression by distinct protein kinase systems in IL-3-dependent myeloid cells.
    Farrar WL; Willette-Brown J; Linnekin D
    Lymphokine Cytokine Res; 1991 Aug; 10(4):291-9. PubMed ID: 1718453
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deregulated c-myc expression overrides IFN gamma-induced macrophage growth arrest.
    Vairo G; Vadiveloo PK; Royston AK; Rockman SP; Rock CO; Jackowski S; Hamilton JA
    Oncogene; 1995 May; 10(10):1969-76. PubMed ID: 7761098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WI-38 cell long-term quiescence model system: a valuable tool to study molecular events that regulate growth.
    Soprano KJ
    J Cell Biochem; 1994 Apr; 54(4):405-14. PubMed ID: 8014189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: possible role of RB as a "status quo" gene.
    Yen A; Chandler S; Forbes ME; Fung YK; T'Ang A; Pearson R
    Eur J Cell Biol; 1992 Apr; 57(2):210-21. PubMed ID: 1511698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells.
    Albert DA
    J Clin Invest; 1995 Apr; 95(4):1490-6. PubMed ID: 7706453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways.
    Packham G; Porter CW; Cleveland JL
    Oncogene; 1996 Aug; 13(3):461-9. PubMed ID: 8760287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-myc Down-regulation in suramin-treated HL60 cells precedes growth inhibition but does not trigger differentiation.
    Ben-Baruch N; Reinhold WC; Alexandrova N; Ichinose I; Blake M; Trepel JB; Zajac-Kaye M
    Mol Pharmacol; 1994 Jul; 46(1):73-8. PubMed ID: 8058059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutive expression of c-myc does not relieve cAMP-mediated growth arrest in human lymphoid Reh cells.
    Andersson KB; Deggerdal A; Skjønsberg C; Smeland EB; Blomhoff HK
    J Cell Physiol; 1993 Oct; 157(1):61-9. PubMed ID: 8408242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of F9 cells is independent of c-myc expression.
    Nishikura K; Kim U; Murray JM
    Oncogene; 1990 Jul; 5(7):981-8. PubMed ID: 1695728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A transactivator of c-myc is coordinately regulated with the proto-oncogene during cellular growth.
    Bazar L; Harris V; Sunitha I; Hartmann D; Avigan M
    Oncogene; 1995 Jun; 10(11):2229-38. PubMed ID: 7784068
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems.
    Pescarolo MP; Bagnasco L; Malacarne D; Melchiori A; Valente P; Millo E; Bruno S; Basso S; Parodi S
    FASEB J; 2001 Jan; 15(1):31-33. PubMed ID: 11099487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Down-regulation of statin, a nonproliferation-specific nuclear protein, and up-regulation of c-myc after initiation of programmed cell death in mouse fibroblasts.
    Wang E; Pandey S
    J Cell Physiol; 1995 Apr; 163(1):155-63. PubMed ID: 7896892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DMSO induced modulation of c-myc steady-state RNA levels in a variety of different cell lines.
    Darling D; Tavassoli M; Linskens MH; Farzaneh F
    Oncogene; 1989 Feb; 4(2):175-9. PubMed ID: 2648255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc.
    Larsson LG; Pettersson M; Oberg F; Nilsson K; Lüscher B
    Oncogene; 1994 Apr; 9(4):1247-52. PubMed ID: 8134128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrated control of cell proliferation and cell death by the c-myc oncogene.
    Evan G; Harrington E; Fanidi A; Land H; Amati B; Bennett M
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug; 345(1313):269-75. PubMed ID: 7846125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.
    Askew DS; Ashmun RA; Simmons BC; Cleveland JL
    Oncogene; 1991 Oct; 6(10):1915-22. PubMed ID: 1923514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential expression of c-myc, max and mxi1 in human myeloid leukemia cells during retrodifferentiation and cell death.
    Meinhardt G; Hass R
    Leuk Res; 1995 Oct; 19(10):699-705. PubMed ID: 7500645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.